711 related articles for article (PubMed ID: 28161590)
21. M-CSF priming of osteoclast precursors can cause osteoclastogenesis-insensitivity, which can be prevented and overcome on bone.
De Vries TJ; Schoenmaker T; Aerts D; Grevers LC; Souza PP; Nazmi K; van de Wiel M; Ylstra B; Lent PL; Leenen PJ; Everts V
J Cell Physiol; 2015 Jan; 230(1):210-25. PubMed ID: 24962140
[TBL] [Abstract][Full Text] [Related]
22. Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation.
Quinn JM; Horwood NJ; Elliott J; Gillespie MT; Martin TJ
J Bone Miner Res; 2000 Aug; 15(8):1459-66. PubMed ID: 10934644
[TBL] [Abstract][Full Text] [Related]
23. Activated T lymphocytes suppress osteoclastogenesis by diverting early monocyte/macrophage progenitor lineage commitment towards dendritic cell differentiation through down-regulation of receptor activator of nuclear factor-kappaB and c-Fos.
Grcević D; Lukić IK; Kovacić N; Ivcević S; Katavić V; Marusić A
Clin Exp Immunol; 2006 Oct; 146(1):146-58. PubMed ID: 16968409
[TBL] [Abstract][Full Text] [Related]
24. Flt3+ macrophage precursors commit sequentially to osteoclasts, dendritic cells and microglia.
Servet-Delprat C; Arnaud S; Jurdic P; Nataf S; Grasset MF; Soulas C; Domenget C; Destaing O; Rivollier A; Perret M; Dumontel C; Hanau D; Gilmore GL; Belin MF; Rabourdin-Combe C; Mouchiroud G
BMC Immunol; 2002 Oct; 3():15. PubMed ID: 12398794
[TBL] [Abstract][Full Text] [Related]
25. Macrophage colony-stimulating factor pretreatment of bone marrow progenitor cells regulates osteoclast differentiation based upon the stage of myeloid development.
Yang X; Pande S; Scott C; Friesel R
J Cell Biochem; 2019 Aug; 120(8):12450-12460. PubMed ID: 30805994
[TBL] [Abstract][Full Text] [Related]
26. Tumor necrosis factor-alpha: alternative role as an inhibitor of osteoclast formation in vitro.
Balga R; Wetterwald A; Portenier J; Dolder S; Mueller C; Hofstetter W
Bone; 2006 Aug; 39(2):325-35. PubMed ID: 16580896
[TBL] [Abstract][Full Text] [Related]
27. Bifurcation of osteoclasts and dendritic cells from common progenitors.
Miyamoto T; Ohneda O; Arai F; Iwamoto K; Okada S; Takagi K; Anderson DM; Suda T
Blood; 2001 Oct; 98(8):2544-54. PubMed ID: 11588053
[TBL] [Abstract][Full Text] [Related]
28. The generation of highly enriched osteoclast-lineage cell populations.
Quinn JM; Whitty GA; Byrne RJ; Gillespie MT; Hamilton JA
Bone; 2002 Jan; 30(1):164-70. PubMed ID: 11792580
[TBL] [Abstract][Full Text] [Related]
29. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
[TBL] [Abstract][Full Text] [Related]
30. Interleukin-18 (interferon-gamma-inducing factor) is produced by osteoblasts and acts via granulocyte/macrophage colony-stimulating factor and not via interferon-gamma to inhibit osteoclast formation.
Udagawa N; Horwood NJ; Elliott J; Mackay A; Owens J; Okamura H; Kurimoto M; Chambers TJ; Martin TJ; Gillespie MT
J Exp Med; 1997 Mar; 185(6):1005-12. PubMed ID: 9091574
[TBL] [Abstract][Full Text] [Related]
31. In vitro induction of inhibitory macrophage differentiation by granulocyte-macrophage colony-stimulating factor, stem cell factor and interferon-gamma from lineage phenotypes-negative c-kit-positive murine hematopoietic progenitor cells.
Ferret-Bernard S; Saï P; Bach JM
Immunol Lett; 2004 Feb; 91(2-3):221-7. PubMed ID: 15019293
[TBL] [Abstract][Full Text] [Related]
32. Generation of CD1+RelB+ dendritic cells and tartrate-resistant acid phosphatase-positive osteoclast-like multinucleated giant cells from human monocytes.
Akagawa KS; Takasuka N; Nozaki Y; Komuro I; Azuma M; Ueda M; Naito M; Takahashi K
Blood; 1996 Nov; 88(10):4029-39. PubMed ID: 8916970
[TBL] [Abstract][Full Text] [Related]
33. Different Blood-Borne Human Osteoclast Precursors Respond in Distinct Ways to IL-17A.
Sprangers S; Schoenmaker T; Cao Y; Everts V; de Vries TJ
J Cell Physiol; 2016 Jun; 231(6):1249-60. PubMed ID: 26491867
[TBL] [Abstract][Full Text] [Related]
34. Resting T cells negatively regulate osteoclast generation from peripheral blood monocytes.
Shinoda K; Sugiyama E; Taki H; Harada S; Mino T; Maruyama M; Kobayashi M
Bone; 2003 Oct; 33(4):711-20. PubMed ID: 14555277
[TBL] [Abstract][Full Text] [Related]
35. Interactions of tumor necrosis factor with granulocyte-macrophage colony-stimulating factor and other cytokines in the regulation of dendritic cell growth in vitro from early bipotent CD34+ progenitors in human bone marrow.
Reid CD; Stackpoole A; Meager A; Tikerpae J
J Immunol; 1992 Oct; 149(8):2681-8. PubMed ID: 1383322
[TBL] [Abstract][Full Text] [Related]
36. Osteoblastic NF-κB pathway is involved in 1α, 25(OH)2D3-induced osteoclast-like cells formation in vitro.
Cong L; Zhang C; Tu G
Int J Clin Exp Pathol; 2015; 8(5):5988-96. PubMed ID: 26191332
[TBL] [Abstract][Full Text] [Related]
37. Tetracyclines convert the osteoclastic-differentiation pathway of progenitor cells to produce dendritic cell-like cells.
Kinugawa S; Koide M; Kobayashi Y; Mizoguchi T; Ninomiya T; Muto A; Kawahara I; Nakamura M; Yasuda H; Takahashi N; Udagawa N
J Immunol; 2012 Feb; 188(4):1772-81. PubMed ID: 22250082
[TBL] [Abstract][Full Text] [Related]
38. The biological roles of the third component of complement in osteoclast formation.
Sato T; Abe E; Jin CH; Hong MH; Katagiri T; Kinoshita T; Amizuka N; Ozawa H; Suda T
Endocrinology; 1993 Jul; 133(1):397-404. PubMed ID: 8319587
[TBL] [Abstract][Full Text] [Related]
39. Regulation of osteoclast differentiation by fibroblast growth factor 2: stimulation of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor expression in osteoblasts and inhibition of macrophage colony-stimulating factor function in osteoclast precursors.
Chikazu D; Katagiri M; Ogasawara T; Ogata N; Shimoaka T; Takato T; Nakamura K; Kawaguchi H
J Bone Miner Res; 2001 Nov; 16(11):2074-81. PubMed ID: 11697804
[TBL] [Abstract][Full Text] [Related]
40. Effects of geranylgeranoic acid in bone: induction of osteoblast differentiation and inhibition of osteoclast formation.
Wang X; Wu J; Shidoji Y; Muto Y; Ohishi N; Yagi K; Ikegami S; Shinki T; Udagawa N; Suda T; Ishimi Y
J Bone Miner Res; 2002 Jan; 17(1):91-100. PubMed ID: 11771673
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
